abstract |
The present invention relates to a dextran nanosel having a surface repeating structure that binds to a pattern recognition RIG-1-like receptor. The dextran nanoparticle of the present invention has little toxicity and side effects, has long-term stability, (RLR) -like receptor (RLR), which mediates innate immune activation and thus inhibits the proliferation of various viruses. Thus, it is possible to provide a pharmaceutical composition for congenital immunization or antiviral, Composition or feed composition. |